Patent ID: 11896575
Assignee: DELIVRA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 18:
19. The transdermal emulsion formulation of claim 1, wherein:
the at least one emulsion stabilizer in the aqueous phase is present in an amount of about 0.2 wt % to about 0.8 wt %;
the at least one emulsifier in the oil phase is present in an amount of about 4 wt % to about 6 wt %;
the at least one emulsion stabilizer in the oil phase is present in an amount of about 2 wt % to about 8 wt %;
the at least one emollient comprising at least one flavonoid in the oil phase is present in an amount of about 5 wt % to about 12 wt %;
the at least one other emollient in the oil phase is present in an amount of about 3 wt % to about 5 wt %;
the terpene-rich natural butter in the oil phase is present in an amount of about 2 wt % to about 5 wt %;the at least one terpene-rich extract or oil is present in an amount of about 0.2 wt % to about 5 wt %;
the at least one penetration enhancer is present in an amount of about 1 wt % to about 2 wt %; and
the phospholipid-complexed flavonoid is present in an amount of about 1.5 wt % to about 2.5 wt %.